Global CALM Implementation Study (Global CALM)
Managing Cancer and Living Meaningfully (CALM): A Global Initiative
Sponsor: University Health Network, Toronto
Terminated
Study recruitment \& data collection ceased in Dec 2022 in part due to funding shortages and the impact of the COVID-19 Pandemic. 40 clinician-participants consented; 35 completed measures; no data were analyzed or published; REB was closed Nov 2024.
Other terminated trials from University Health Network, Toronto
- ACL Injury · Apr 2026
- Endometrial Carcinoma · Phase PHASE2/PHASE3 · May 2025
- Intrahepatic Cholangiocarcinoma · Phase PHASE2 · Dec 2024
- Central Venous Catheter Thrombosis · Phase PHASE3 · Oct 2024
- Hepatocellular Carcinoma · Phase PHASE2 · Feb 2024
See all terminations from University Health Network, Toronto
Listed as NCT04499690, this observational or N/A phase trial focuses on Depression and remains terminated or withdrawn. Sponsored by University Health Network, Toronto, it has been updated 7 times since 2019, reflecting limited change activity. Mental health research at this phase helps define safety and dosing parameters for future study.
Status Flow
Change History
7 versions recorded-
Aug 2025 — Present [monthly]
Terminated
Status: Active Not Recruiting → Terminated
-
Sep 2024 — Aug 2025 [monthly]
Active Not Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting
-
Jan 2024 — Jul 2024 [monthly]
Active Not Recruiting
-
Jul 2023 — Jan 2024 [monthly]
Active Not Recruiting
Status: Enrolling By Invitation → Active Not Recruiting
▶ Show 2 earlier versions
-
Jan 2021 — Jul 2023 [monthly]
Enrolling By Invitation
-
Sep 2020 — Jan 2021 [monthly]
Enrolling By Invitation
First recorded
Jun 2019
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University Health Network, Toronto
For direct contact, visit the study record on ClinicalTrials.gov .